OTCMKTS:ABCZY

Abcam - ABCZY News Today

$19.40

+0.52 (+2.75%)

(As of 10/29/2020)

Add

Compare

Today's Range: $19.09
▼
$19.40
50-Day Range: $19.40
▼
$19.40
52-Week Range: $11.26
▼
$19.73

Volume: 5,400 shs
Average Volume: 4,712 shs
Market Capitalization: $3.98 billion

P/E Ratio: N/A
Dividend Yield: 0.36%
Price Target: N/A

Get Abcam News Delivered to You Automatically

ABCZY Media Mentions By Week

ABCZY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABCZY
News Sentiment
▼
0.00

0.35
▲
Average
Medical
News Sentiment

ABCZY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABCZY Articles
This Week
▼
0

0
▲
ABCZY Articles
Average Week

Source

Source	Headline
	Abcam unveils plaques honouring 41 scientists behind BRCA2 breast cancer gene discovery msn.com - February 6 at 10:26 AM
	NanoString and Abcam Expand Collaboration to Advance Spatial Multiomics Research technews.tmcnet.com - November 9 at 7:26 AM
	Abcam Seeks Approval to Cancel AIM Listing marketwatch.com - October 17 at 4:27 AM
	Abcam: A Good Growth Stock In The Healthcare Market seekingalpha.com - September 29 at 9:44 AM
	Abcam ADS Non-GAAP EPS of 14.00p, revenue of £185.2M seekingalpha.com - September 14 at 8:09 AM
	Abcam plc (ABCM) Q4 2022 Earnings Call Transcript seekingalpha.com - September 12 at 4:06 PM
	Abcam PLC PK (ABCZY) investing.com - July 25 at 11:40 PM
	Cambridge biotech Abcam to abandon London listing for Nasdaq ft.com - July 20 at 3:28 PM
	Are analysts upbeat on the outlook for Abcam? uk.finance.yahoo.com - July 1 at 8:44 AM
	Abcam the most awarded company at 2022 industry awards tmcnet.com - March 25 at 8:36 AM
	Wall Street Analysts Predict a 27% Upside in Abcam PLC Sponsored ADR (ABCM): Here's What You Should Know nasdaq.com - March 18 at 1:26 PM
	Abcam completes acquisition of life science research tool distributor lse.co.uk - October 27 at 8:19 AM
	Abcam to buy BioVision for $340m lse.co.uk - August 2 at 9:19 AM
	‘Amazon of antibodies’ Abcam buys up US supplier BioVision in $340million deal uk.finance.yahoo.com - August 2 at 9:19 AM
	Abcam to acquire Boai NKY subsidiary BioVision for USD340 million lse.co.uk - August 2 at 4:19 AM
	Abcam to Buy BioVision for $340 Mln-- Deal Digest marketwatch.com - August 2 at 4:19 AM
	Abcam To Buy US-based BioVision For $340 Mln - Quick Facts nasdaq.com - August 2 at 4:19 AM
	Abcam Says Underlying Performance Has Been Modestly Ahead of Expectations marketwatch.com - July 1 at 10:28 AM
	Abcam trades in line with expectations as lab product demand limited lse.co.uk - July 1 at 10:28 AM
	Some Shareholders May find It Hard To Increase Abcam plc's (LON:ABC) CEO Compensation This Year ca.finance.yahoo.com - June 25 at 7:53 AM
	Abcam and MEDx extend precision medicine strategic partnership finance.yahoo.com - April 12 at 7:45 AM
	Abcam Expands Presence in China to Support Increased Demand of BioPharma Sector finance.yahoo.com - March 4 at 7:41 AM
	Can You Imagine How Jubilant Abcam's (LON:ABC) Shareholders Feel About Its 164% Share Price Gain? finance.yahoo.com - January 29 at 6:32 AM
	Abcam Expects Good Interim Results As Most Regions Experience Growth lse.co.uk - January 11 at 9:21 AM
	Abcam Reaches Analyst Target Price nasdaq.com - December 31 at 9:42 AM
	Abcam reveals new cell engineering facility in Bay Area finance.yahoo.com - December 8 at 7:20 AM
	Key Things To Understand About Abcam's (LON:ABC) CEO Pay Cheque finance.yahoo.com - December 6 at 2:22 AM
	Abcam Nets Additional USD24 Million Under ADS Offering lse.co.uk - October 23 at 3:23 PM
	Research Tool provider Abcam prices IPO at $17.50/ADS seekingalpha.com - October 22 at 8:20 AM
	Abcam Prices Initial Public Offering Of ADSs On Nasdaq Market lse.co.uk - October 22 at 8:20 AM
	Abcam PLC Registered Shares LS (A8C1.SG) au.finance.yahoo.com - October 15 at 8:00 AM
	Abcam Proposes US Stock Listing; Co-Founder To Step Down From Board lse.co.uk - October 5 at 10:34 AM
	Earnings Miss: Abcam plc Missed EPS By 52% And Analysts Are Revising Their Forecasts finance.yahoo.com - September 17 at 3:36 AM
	Abcam plc (ABCZF) CEO Alan Hirzel on Q4 2020 Results - Earnings Call Transcript seekingalpha.com - September 16 at 7:34 AM
	Abcam Pays No Final Dividend As Annual Profit Plunges Amid Covid Costs lse.co.uk - September 14 at 10:01 AM
	Is there momentum behind the Abcam share price? uk.finance.yahoo.com - August 17 at 7:32 AM
	Are Robust Financials Driving The Recent Rally In Abcam plc's (LON:ABC) Stock? finance.yahoo.com - July 22 at 6:10 AM
	Are Robust Financials Driving The Recent Rally In Abcam plc's (LON:ABC) Stock? finance.yahoo.com - July 22 at 6:10 AM
	Can Abcam ride out the Covid-19 economic shock? uk.finance.yahoo.com - June 19 at 8:56 AM
	Does Abcam (LON:ABC) Have A Healthy Balance Sheet? finance.yahoo.com - May 23 at 5:00 AM
	Where next for the Abcam share price? uk.finance.yahoo.com - April 27 at 7:55 AM
	Announcing: Abcam (LON:ABC) Stock Increased An Energizing 132% In The Last Five Years finance.yahoo.com - March 12 at 8:12 AM
	Abcam Buys US's Marker Gene Technologies, Issues GBP600,000 In Shares www.lse.co.uk - March 4 at 8:34 AM
	Abcam Buys Applied StemCell Gene Editing Platform, Oncology Portfolio www.lse.co.uk - January 30 at 8:07 AM
	What Abcam plc's (LON:ABC) ROE Can Tell Us finance.yahoo.com - January 28 at 8:51 AM
	Abcam Appoints Ondra Founding Partner Baldock As Finance Chief www.lse.co.uk - January 14 at 4:59 AM
	Abcam Completes Expedeon Proteomics And Immunology Business Buy www.lse.co.uk - January 2 at 6:59 AM
	UPDATE: Abcam Says Well Placed After Purchase Of Expedeon Businesses www.lse.co.uk - January 2 at 6:59 AM
	Abcam and BrickBio announce a partnership to incorporate conjugation-ready sites into recombinant antibodies across Abcam's portfolio markets.businessinsider.com - November 8 at 8:46 AM
	IGY Polyclonal Antibodies Market is growing at an exponential rate by 2025 \| Key players: Merck, IGY Life Sciences, Abcam www.marketwatch.com - November 6 at 9:00 AM

Get Abcam News Delivered to You Automatically

This page (OTCMKTS:ABCZY) was last updated on 3/21/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Abcam - ABCZY News Today

ABCZY Media Mentions By Week

ABCZY Media Sentiment

ABCZY News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info